Abstract
Diagnosis and treatment of Alzheimer Disease should be supported by epidemiological data and by costs of its overall impact. Developing countries, with uncertain economic future, have higher prevalence and incidence of dementia.
This paper present a narrative review of demographic, statistical, governmental and economic studies of dementia and the burden of this disease in health services
References
ROSSELLI D, ARDILA A, PRADILLA G, ET AL. The Mini-Mental State Examination as a selected diagnostic test for dementia: a Colombian population study. Rev Neurol 2000; 30: 428–32.
PRADILLA G, VESGA BE, LEON-SARMIENTO FE, ET AL. Neuroepidemiology in the eastern region of Colombia Rev Neurol 2002; 34: 1035–43.
PRADILLA G, VESGA BE, LEÓN FE Y GENECO. Estudio Neuroepidemiológico Nacional (EPI- NEURO) Colombiano. Pan Am J Puclic Health 2003; 14: 104-111.
CUSTODIO N, GUTIERREZ C, GARCIA A. Prevalencia de demencia en una comunidad urbana de Lima: un estudio puerta a puerta . Proceedings of the XII Pan-American Congress of Neurology, Santo Domingo, Dominican Republic; Oct 11–17, 2007: 17.
MOLERO AE, PINO-RAMIREZ G, MAESTRE GE. High prevalence of dementia in a Caribbean population. Neuroepidemiology 2007; 29: 107–12.
PAGES-LARRAYA FP, MARI G. Prevalence of dementia of the Alzheimer’s type, vascular demen- tia and other dementias in the city of Buenos Aires . Acta Psiquiat Psicol Am Lat 1999; 45: 122–141.
HERRERA E JR, CARAMELLI P, SILVEIRA AS, NITRINI R. Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord 2002; 16: 103–08.
FERRI C, PRINCE M, BRAYNE M, BRODATY H, FRATIGLIONI L, GANGULI M, HALL K, HASEGAWA K, HENDRIE H, HUANG Y. Global prevalence of dementia: a Delphi consensus study The Lancet 2005; 9503: 2112-2117
http://www.dane.gov.co/files/investigaciones/ poblacion/proyepobla06_20/7Proyecciones_pobla- cion.pdf.
RUIZ DE S C, CAMARGO L, MATALLANA D, MONTAÑEZ P, ET AL. Una experiencia de 2600 val- oraciones y 1918 casos de la clínica de Memoria de la Universidad Javeriana y el Hospital Universitario de San Ignacio durante doce años (1997ª 2009). Poster Congreso Colombiano de Neurología, Acta Neurol Colomb Sept 2009; 25:170.
HELMER C, PASQUIER F, DARTIGUES JF. Epi- demiology of Alzheimer disease and related disor- ders. Medecine/Science 2006; 22:1-18.
LOBO A, LAUNER LJ, FRATIGLIONI L, ANDERSEN K, DI CARLO A, BRETELER MM ET AL. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54:4-9.
RAMAROSON H, HELMER C, BARBERGER- GATEAU P, ET AL. Prévalence de la démence et de la maladie d’Alzheimer chez les personnes de 75 ans et plus : données réactualisées de la cohorte Paquid. Rev Neurol 2003; 159: 405-11.
DE RONCHI D, BERARDI D, MENCHETTI M, ET AL. Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. Dement Geriatr Cogn Disord 2005; 19: 97-105.
FITZPATRICK AL, KULLER LH, IVES DG, ET AL. Incidence and prevalence of dementia in the Car- diovascular health study. J Am Geriatr Soc 2004 ; 52: 195-204.
HOFMAN A, ROCCA WA, BRAYNE C, BRE- TELER MM, CLARKE M, COOPER B ET AL. The prevalence of dementia in Europe: a collaborative study of 1980–1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol 1991;20:736-48.
RITCHIE K, KILDEA D. Is senile dementia “age- related” or “ageing-related”? – evidence from meta- analysis of dementia prevalence in the oldest old. Lancet 1995;346:931-34.
FRATIGLIONI L, DE RONCHI D, AGUERO- TORRES H. Worldwide prevalence and incidence of dementia. Drugs Aging 1999;15:365-75.
MANGONE CA, ARIZAGA RL. Dementia in Argentina and other Latin- American countries: An overview. Neuroepidemiology 1999;18:231-35.
Dementia Etiology and Epidemiology The Swed- ish Council on Technology Assessment in Health Care 2008.
RATNAVALLI E, BRAYNE C, DAWSON K, HODGES J. The prevalence of frontotemporal dementia. Neurology 2002;11:1615-21.
RUIZ DE S C, CAMARGO L, MATALLANA D, MONTAÑEZ P, ET AL. Frecuencia diagnóstica y car- acterísticas de la Degeneración Frontotemporal de la Clínica de Memoria de la Universidad Javeriana y el Hospital Universitario de San Ignacio durante doce años (1997 a 2009). Poster Congreso Colombiano de Neurología, Acta Neurol Colomb 2009; 25:170.
COMAS-HERRERA, A, WITTENBERG R, PICK- ARD L, KNAPP M. Discussion Paper 2005. Cognitive impairment inolder people; its implications for future demand for services and costs; 1728.
LANGA KM, CHERNEW ME, KABETO MU, ET AL. National estimates of the quantity and cost of informal caregiving for the elderly wit dementia. J Gen intern Med 2001;16:770-78.
TAYLOR DH JR, SLOAN FA. How much do per- sons with Alzheimer´s disease cost Medicare? J AM Geriatr Soc 2000;48.639-46.
MITTELMAN MS, HALEY WE, CLAY OJ, RITH DL. Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease. Neurology 2006; 67: 1592-9.
VALCOUR VG, MASAKI KH, CURB JD, BLANCHETTE PL. The detection of dementia in the primary care setting. Arch Intern Med. 2000; 160:2964-8.
BULLOCK R, DENGIZ A, Cognitive performance in patients wit Alzeimer´s disease receiving cholines- terase inhibitors for up to five years. IntJ CLin Pract 2005; 59 : 817-22.
SKOOG I, LERNFELT B, LANDAHL S, ET AL. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-5.
LAUNER LJ, ROSS GW, PETROVITCH H, ET AL. Midlife blood pressure and dementia: the Hono- lulu-Asia aging study. Neurobiol Aging 2000; 21: 49-55.
KIVIPELTO M, HELKALA E-L, LAASKO MP, ET AL. Midlife vascular risk factors and Alzheimer’s dis- ease in later life: longitudinal, population based study. Br Med J 2001; 322: 1447-51.
OTT A, STOLK RP, HOFMAN A, ET AL. Asso- ciation of diabetes mellitus and dementia: the Rot- terdam study. Diabetologia 1996; 39: 1392-7.
KNOPMAN D, BOLAND LL, MOSLEY T, ET AL. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42-8.
XU WL, QIU CX, WAHLIN A, ET AL. Diabetes mellitus and risk of dementia in the Kungsholmen project ç: a 6-year follow-up study. Neurology 2004; 63: 1181-1186.
GRAVES A, VAN DUIJN C, CHANDRA V, ET AL. Alcohol and tobacco consumption as risk factors for Alzheimer’s disease: a collaborative reanalysis of case-control studies. Eurodem risk factors research group. Int J Epidemiol 1991; 20: 48-57.
OTT A, SLOOTER AJ, HOFMAN A, ET AL. Smoking and risk of dementia and Alzheimer’s dis- ease in a population-based cohort study: the Rotter- dam Study. Lancet 1998; 351: 1840-3.
JUAN D, ZHOU DH, LI J, ET AL. A 2-year follow- up study of cigarette smoking and risk of dementia. Eur J Neurol 2004; 11: 277-82.
GUSTAFSON D, ROTHENBERG E, BLENNOW K, ET AL. An-18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 2003; 163: 1524-8.
DESMOND DW, MORONEY JT, SANO M, STERN
Y. Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 2002; 33: 2254-60.
LOWERY K, BALLARD C, RODGERS H, ET AL. Cognitive decline in a prospectively studied group of stroke survivors, with a particular emphasis on the > 75’s. Age Ageing 2002; 31 (suppl 3): 24-7.
IVAN CS, SESHADRI S, BEISER A, ET AL. Dementia after stroke: the Framingham study. Stroke 2004; 35: 1264-8.
ALTIERI M, DI PIERO V, PASQUINI M, ET AL. Delayed poststroke dementia: a 4-year follow-up study. Neurology 2004; 62: 2193-7.
OTT A, BRETELER MMB, DE BRUYNE MC, ET AL. Atrial fibrillation and dementia in a pop- ulation-based study. The Rotterdam study. Stroke 1997;28 316-21.
HOFMAN A, OTT A, BRETELER MMB, ET AL. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet 1997; 349: 151-4.
HOGERVORST E, RIBEIRO HM, MOLYNEUX A, ET AL. Plasma homocysteine levels, cerebrovas- cular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 2002; 59: 787-93.
WEIMER D, SAGER M. Early identification and treatment of Alzheimer´s disease: Social and fiscal outcomes. Alzhiemers Dement, 209; 5: 215-226.
BUSTANI M, CALLAHAN CM, UNVERZAGT FFW, AUSTROM MG, PERKINS AJ, FULTZ B, ET AL. Implementing a screening and diagnosis program for dementia in primary care. J Gen Intern Med
;20:572-7.
BRAYNE C, FOX C, BOUSTANI M. Dementia screening in primary care. Is it time? JAMA 2007; 298:2409-11.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.